Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
26.02. | Tjoapack Begins First Production of Pre-Filled Syringes in Europe | ||
26.02. | HBM Alpha Therapeutics Strikes $395M Deal for CRH Antibody Therapy | ||
26.02. | ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery | ||
26.02. | AI Drug Turnaround Startup, Ignota Labs, Raises $6.9M | ||
25.02. | Nimbus Therapeutics Achieves Lilly Research Milestone | ||
25.02. | IsomAb Names Dr. Gary Burgess as Chief Medical Officer | ||
25.02. | BridGene Biosciences, Takeda Partner to Discover Small Molecule Drugs | ||
25.02. | Ephicacy Names Tara Gladwell as CEO | ||
25.02. | RedHill Licenses RHB-102 to Hyloris | ||
25.02. | Thermo Fisher Scientific to Acquire Solventum's Purification & Filtration Business | ||
24.02. | Swarm Oncology Partners with Cellex to Advance T Cell Therapies for Solid Cancers | ||
24.02. | GSK Acquires IDRx | ||
24.02. | FDA Accepts Bristol Myers Squibb's sBLA for Opdivo Plus Yervoy | ||
24.02. | Kineticos Life Sciences Introduces Kinvard Bio | ||
24.02. | Maravai LifeSciences Acquires DNA and RNA Business of Officinae Bio | ||
21.02. | AstraZeneca 4Q Results | ||
21.02. | atai Acquires Psilera's DMT Patent Portfolio | ||
21.02. | Andelyn Biosciences Expands AAV Curator Platform Offering | ||
21.02. | Teva, Alvotech Launch SELARSDI, Stelara Biosimilar | ||
21.02. | Tiziana Life Sciences & Renaissance Partner on Nasal Foralumab Production | ||
20.02. | Eleva Appoints New Chief Medical Officer | ||
20.02. | Harbour BioMed & Insilico Partner on AI-Driven Antibody Discovery | ||
20.02. | Thermo Fisher Scientific Launches NanoDrop Ultra | ||
20.02. | Rentschler Biopharma Appoints Patrick Meyer Global Head of BD | ||
20.02. | Boehringer Ingelheim Names Brian Hilberdink as President, U.S. Human Pharma |